FindTrial
Sign In

A clinical trial to study the benefits of adding pressure device in treatment of Chronic Obstructive Pulmonary Disease patients

Therapeutic efficacy of Oscillating Positive Expiratory Pressure therapy in stable Chronic Obstructive Pulmonary Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030725
Enrollment
50
Registered
2021-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Oscillating Positive Expiratory Pressure Therapy: 2 puffs every 10-20 breaths for 15 minutes along with routine Chronic Obstructive Pulmonary Disease treatment as per gold guidelines Co

Sponsors

Dr Varinder Saini
Lead Sponsor
Professor and Head Dr Varinder Saini
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Group c and D COPD patients diagnosed as per GOLD guidelines who are clinically stable for the past 1 month

Exclusion criteria

Exclusion criteria: 1. COPD patients in group A and B as per GOLD guidelines. 2. Patients with history of exacerbation in the past 1 month. 3. COPD patients with hemoptysis, rib fracture, pneumothorax, right and left cardiac decompensation and infection at the beginning of trial. 4. patients who do not give consent for the study.

Design outcomes

Primary

MeasureTime frame
spirometry, six minutes walk test, St. George Respiratory Questionnaire and COPD assessment testTimepoint: 3 months—

Secondary

MeasureTime frame
rate of acute exacerbationTimepoint: 3 months—

Countries

India

Contacts

Public ContactAayushi Gupta

Government Medical College and Hospital, sector 32, Chandigarh

Pulmed1994@gmail.com978896100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026